Budd‐Chiari syndrome on background of JAK2V617F mutation with no hematologic abnormalities
journal contribution
submitted on 2023-03-15, 08:01 and posted on 2023-03-16, 06:20 authored by Ammara Bint I Bilal, Fateen Ata, Mohamed Abdelrazek, Mohamed A. YassinWhenever considering idiopathic Budd-Chiari syndrome, consider the possibility of JAK2 mutation even if clinical parameters are within normal range.
Other Information
Published in: Clinical Case Reports
License: http://creativecommons.org/licenses/by/4.0/
See article on publisher's website: http://dx.doi.org/10.1002/ccr3.4668
History
Language
- English
Publisher
WileyPublication Year
- 2021
Institution affiliated with
- Hamad Medical Corporation
- National Center for Cancer Care and Research (Hamad Medical Corporation)
